SCHEMBL8690111

SCHEMBL8690111

O=C(O)Cc1cc(Br)cc2c1OCO2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C19 P33261 2/20 0.37
MAPK1 P28482 1/20 0.35
HSP90AA1 P07900 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
AGBL2 Q5U5Z8 1/20 0.34
GLO1 Q04760 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
NPC1 O15118 2/20 0.33
AOC3 Q16853 1/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33
GAA P10253 1/20 0.33
MC4R P32245 1/20 0.33
PPARG P37231 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16396205 0.81 CFD (0.46) ALDH1A1
SCHEMBL6542530 0.79 CYP3A4 (0.39) ALDH1A1CYP1A2CYP3A4CYP2C19MAPK1
SCHEMBL14027056 0.79 POLB (0.35) ALDH1A1CYP3A4HSP90AA1MEN1KMT2A
SCHEMBL4064131 0.77 AHR (0.34) ALDH1A1CYP3A4AOC3POLB
SCHEMBL31480938 0.76 AKR1C3 (0.43) RAB9AALDH1A1CYP1A2MAPK1KDM4C
SCHEMBL4492453 0.76 AKR1C3 (0.43) RAB9AALDH1A1CYP1A2MAPK1KDM4C
SCHEMBL10534396 0.74 ALDH1A1 (0.50) RAB9AALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL29061284 0.74 CYP3A4 (0.44) RAB9AALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL3402977 0.72 KDM4C (0.50) ALDH1A1MAPK1KDM4CAGBL2KDM4E
SCHEMBL4630276 0.72 NPC1 (0.38) RAB9AALDH1A1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807860-A ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE INHIBITORS; HYPERLIPEMIA, ATHEROSCLEROSIS; ANTICHOLESTEROL AGENTS MITSUBISHI CHEMICAL CORPORATION (JP) 1998-09-15 US disclosed
EP-0773218-A1 N-(Piperazinylalkoxyphenyl)-N'phenylalkylurea derivatives as ACAT inhibitors for the treatment of atheroschlerosis MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 EP disclosed